Survival rate is near-normal in Lambert-Eaton myasthenic syndrome without malignancy


  • Individuals with Lambert-Eaton myasthenic syndrome (LEMS) without an associated lung cancer have normal survival, stable disease course and remain independent for self-care.

  • Tumor survival is longer in people with LEMS with small cell lung cancer (SCLC) compared with those who have SCLC without LEMS.

Why this matters

    Increased understanding of the prognosis and limitations in LEMS is useful for guiding the expectations and treatment choices of physicians and affected individuals.